Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s ...

Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

It’s a fine measure of the curator Joel Smith’s visual and emotional acuity that the first standout images one encounters on ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerat ...

Dompé advances cenegermin-bkbj into Phase 3 for NAION, a rapid vision-loss condition with no FDA-approved treatment options.

New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology ...

SNU Eye Clinic explains why early cataract symptoms are often mistaken for presbyopia and why comprehensive eye ...

A recent study found that regular cultural engagement, such as attending the cinema, theater, or museums, may help slow ...

A woman born with almost no functional vision because of a genetic mutation has regained measurable sight after a single ...